January 10, 2020
Constellation Pharmaceuticals
Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
January 09, 2020
Nurix
Nurix Therapeutics and Sanofi Establish Strategic Collaboration to Develop Novel Targeted Protein Degradation Therapies
January 09, 2020
Jounce Therapeutics
Jounce Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 09, 2020
Editas Medicine
Editas Medicine Strengthens Executive Leadership Team To Support Long-Term Growth
January 09, 2020
Blueprint Medicines
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor